Correlation Between Antisense Therapeutics and AusCann Group
Can any of the company-specific risk be diversified away by investing in both Antisense Therapeutics and AusCann Group at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Antisense Therapeutics and AusCann Group into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Antisense Therapeutics Limited and AusCann Group Holdings, you can compare the effects of market volatilities on Antisense Therapeutics and AusCann Group and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Antisense Therapeutics with a short position of AusCann Group. Check out your portfolio center. Please also check ongoing floating volatility patterns of Antisense Therapeutics and AusCann Group.
Diversification Opportunities for Antisense Therapeutics and AusCann Group
0.46 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Antisense and AusCann is 0.46. Overlapping area represents the amount of risk that can be diversified away by holding Antisense Therapeutics Limited and AusCann Group Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AusCann Group Holdings and Antisense Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Antisense Therapeutics Limited are associated (or correlated) with AusCann Group. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AusCann Group Holdings has no effect on the direction of Antisense Therapeutics i.e., Antisense Therapeutics and AusCann Group go up and down completely randomly.
Pair Corralation between Antisense Therapeutics and AusCann Group
Assuming the 90 days horizon Antisense Therapeutics is expected to generate 23.97 times less return on investment than AusCann Group. But when comparing it to its historical volatility, Antisense Therapeutics Limited is 4.71 times less risky than AusCann Group. It trades about 0.03 of its potential returns per unit of risk. AusCann Group Holdings is currently generating about 0.17 of returns per unit of risk over similar time horizon. If you would invest 0.25 in AusCann Group Holdings on October 23, 2024 and sell it today you would earn a total of 0.13 from holding AusCann Group Holdings or generate 52.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 83.99% |
| Values | Daily Returns |
Antisense Therapeutics Limited vs. AusCann Group Holdings
Performance |
| Timeline |
| Antisense Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| AusCann Group Holdings |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Antisense Therapeutics and AusCann Group Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Antisense Therapeutics and AusCann Group
The main advantage of trading using opposite Antisense Therapeutics and AusCann Group positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Antisense Therapeutics position performs unexpectedly, AusCann Group can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AusCann Group will offset losses from the drop in AusCann Group's long position.| Antisense Therapeutics vs. Amexdrug | Antisense Therapeutics vs. Aion Therapeutic | Antisense Therapeutics vs. Alterola Biotech | Antisense Therapeutics vs. The BC Bud |
| AusCann Group vs. Amexdrug | AusCann Group vs. Aion Therapeutic | AusCann Group vs. Alterola Biotech | AusCann Group vs. The BC Bud |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Complementary Tools
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |